Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1958 1
1962 1
1964 1
1965 3
1967 7
1968 12
1969 18
1970 24
1971 28
1972 19
1973 24
1974 18
1975 17
1976 16
1977 3
1978 3
1979 1
1980 3
1981 1
1982 5
1983 7
1984 8
1985 2
1986 10
1987 3
1988 3
1989 8
1990 8
1991 9
1992 6
1993 10
1994 11
1995 10
1996 13
1997 7
1998 10
1999 12
2000 18
2001 18
2002 23
2003 24
2004 48
2005 47
2006 58
2007 75
2008 77
2009 87
2010 115
2011 127
2012 155
2013 152
2014 165
2015 175
2016 181
2017 172
2018 187
2019 194
2020 223
2021 228
2022 212
2023 203
2024 195
2025 82

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,079 results

Results by year

Filters applied: . Clear all
Page 1
Sociodemographic influences on substance use in psychosis in an African cohort.
Campbell ML, Odokonyero R, Akena D, Alemayehu M, Atwoli L, Chibnik LB, Gelaye B, Gichuru S, Kariuki SM, Koenen KC, Kwobah E, Kyebuzibwa J, Mwema RM, Newton CRJC, Post K, Pretorius A, Stevenson A, Stroud RE 2nd, Teferra S, Zingela Z, Stein DJ, Hook K. Campbell ML, et al. Schizophr Res. 2025 May 10;281:157-163. doi: 10.1016/j.schres.2025.04.012. Online ahead of print. Schizophr Res. 2025. PMID: 40349466
BACKGROUND: Substance use is common among individuals with psychotic disorders, but limited research exists on the variations in substance use across countries in Africa. ...METHODS: We utilized data from the Neuropsychiatric Genetics of African Populations-Psych …
BACKGROUND: Substance use is common among individuals with psychotic disorders, but limited research exists on the variations …
Adverse clinical effects associated with the use of synthetic cannabinoids: A systematic review.
Prete MM, Feitosa GTB, Ribeiro MAT, Fidalgo TM, Sanchez ZM. Prete MM, et al. Drug Alcohol Depend. 2025 Apr 30;272:112698. doi: 10.1016/j.drugalcdep.2025.112698. Online ahead of print. Drug Alcohol Depend. 2025. PMID: 40334326 Review.
Synthetic cannabinoids (SCs) are potent agonists of CB1 and CB2 receptors, with affinities approximately 100 times greater than that of natural cannabis. This increased potency is associated with severe clinical outcomes, including psychosis, dependence, and various …
Synthetic cannabinoids (SCs) are potent agonists of CB1 and CB2 receptors, with affinities approximately 100 times greater than that of natu …
Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.
Mustonen A, Taipale H, Denissoff A, Ellilä V, Di Forti M, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J, Niemelä S. Mustonen A, et al. Br J Psychiatry. 2025 May 6:1-7. doi: 10.1192/bjp.2025.72. Online ahead of print. Br J Psychiatry. 2025. PMID: 40326094
BACKGROUND: Cannabis use is linked to treatment non-adherence and relapses in psychotic disorders. Antipsychotic medication is effective for relapse prevention in primary psychoses, but its effectiveness after cannabis-induced psychosis (CIP) re …
BACKGROUND: Cannabis use is linked to treatment non-adherence and relapses in psychotic disorders. Antipsychotic medica …
Cannabis and psychopathology: 2024 Snapshot of a meandering journey.
Mahintamani T, Mukherjee D, Basu D. Mahintamani T, et al. Indian J Psychiatry. 2025 Mar;67(3):283-302. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_968_24. Epub 2025 Mar 14. Indian J Psychiatry. 2025. PMID: 40291036 Free PMC article. Review.
AIMS: This narrative review of a comprehensive literature search over the past 10 years aims to provide an update and current understanding, while raising unanswered questions for the future, focusing on the following areas: (a) nosological changes in cannabis-related psyc …
AIMS: This narrative review of a comprehensive literature search over the past 10 years aims to provide an update and current understanding, …
Effects of legal access versus illegal market cannabis on use and mental health: A randomized controlled trial.
Baltes-Flueckiger L, Steinauer R, Meyer M, Guessoum A, Herrmann O, Mosandl CF, Kronschnabel J, Pichler EM, Vogel M, Walter M. Baltes-Flueckiger L, et al. Addiction. 2025 Apr 28. doi: 10.1111/add.70080. Online ahead of print. Addiction. 2025. PMID: 40289676
MEASUREMENTS: The primary outcome was self-reported severity of cannabis misuse after 6 months, as measured by the Cannabis Use Disorders Identification Test - Revised (range 0-32). Secondary outcomes involved depressive, anxiety, and psychotic symptom …
MEASUREMENTS: The primary outcome was self-reported severity of cannabis misuse after 6 months, as measured by the Cannabis Us …
Effect of cannabinoids on glutamate levels in the human brain: a systematic review and meta-analysis.
Urbi B, Sapaen V, Hughes I, Owusu MA, Sabet A, Broadley SA. Urbi B, et al. J Cannabis Res. 2025 Apr 21;7(1):21. doi: 10.1186/s42238-025-00277-9. J Cannabis Res. 2025. PMID: 40259403 Free PMC article. Review.
Most of the observational studies in this review demonstrated a reduction in glutamate in the brain of chronic cannabis users. However, these findings are not definitive and will require further confirmations. This review suggests that acute cannabis administration …
Most of the observational studies in this review demonstrated a reduction in glutamate in the brain of chronic cannabis users. Howeve …
Cannabis use and psychotic-like experiences: A systematic review of biological vulnerability, potency effects, and clinical trajectories.
Ricci V, Chiappini S, Martinotti G, Maina G. Ricci V, et al. Psychiatry Res. 2025 Jun;348:116496. doi: 10.1016/j.psychres.2025.116496. Epub 2025 Apr 15. Psychiatry Res. 2025. PMID: 40252295 Review.
Epidemiological data have provided evidence that psychotic-like experiences (PLEs) occur in the general population without clinical impairment. ...Early identification of PLEs in young cannabis users represents a crucial opportunity for targeted clinical interventio …
Epidemiological data have provided evidence that psychotic-like experiences (PLEs) occur in the general population without clinical i …
PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample.
Tognin S, Vieira S, Oliver D, Cullen AE, Kempton MJ, Fusar-Poli P, Mechelli A, Dazzan P, Merritt K, Maat A, de Haan L, Lawrie SM, van Amelsvoort T, Arango C, Nelson B, Galderisi S, Bressan R, Kwon JS, Mizrahi R; PSYSCAN Consortium; Kahn RS, McGuire P. Tognin S, et al. Schizophrenia (Heidelb). 2025 Apr 17;11(1):66. doi: 10.1038/s41537-025-00598-x. Schizophrenia (Heidelb). 2025. PMID: 40246889 Free PMC article.
Over the follow-up period, 25 CHR individuals (10.5%) transitioned to psychosis. However, the CHR group as a whole showed improvements in functioning and attenuated psychotic symptoms. Similar to other recent multi-centre studies, the CHR cohort exhibits high comorb …
Over the follow-up period, 25 CHR individuals (10.5%) transitioned to psychosis. However, the CHR group as a whole showed improvement …
DEMOGRAPHIC PROFILE, SUBSTANCE USE TRENDS AND ASSOCIATED PSYCHOTIC DISORDERS AMONG VETERANS WITH MENTAL HEALTH CONDITIONS: A RETROSPECTIVE COHORT STUDY OF US VETERANS.
Obermann J, Divadeenam K, Flynn AV, Thakur H, Singh V, Sharma R, Wiegmann T, Boinpelly V, Grasing K, Sharma M, Sharma R. Obermann J, et al. ASEAN J Psychiatry. 2024 Jul 12;2024:10.54615/2231-7805.47358. doi: 10.54615/2231-7805.47358. ASEAN J Psychiatry. 2024. PMID: 40242831
AIMS: To understand the demographic profile, substance use trends, psychotic disorders and suicide attempts in veterans hospitalized with acute Mental Health Conditions (MHC). ...CONCLUSIONS: Among US Veterans with MHC, amphetamine was most used substance associated …
AIMS: To understand the demographic profile, substance use trends, psychotic disorders and suicide attempts in veterans hospit …
Proof-of-Concept Pilot Study on the Integration of a Contingency Management Model to Address Substance Use Among Individuals Enrolled in Early Intervention Programs for Psychosis.
Oluwoye O, Puzia M, Stokes B, Fraser ER, Stokes S, Siddiqi K, Roll JM. Oluwoye O, et al. Early Interv Psychiatry. 2025 Apr;19(4):e70037. doi: 10.1111/eip.70037. Early Interv Psychiatry. 2025. PMID: 40235187 Free PMC article.
BACKGROUND: Studies have reported high rates of alcohol and cannabis use and poor outcomes associated with substance use among individuals enrolled in coordinated specialty care (CSC) for first episode psychosis (FEP). ...At baseline, 78% of participants reported …
BACKGROUND: Studies have reported high rates of alcohol and cannabis use and poor outcomes associated with substance use among indivi …
3,079 results

Searches related to "marijuana psychosis"